BILL Holdings, Inc. (LON:0A75)
London · Delayed Price · Currency is GBP · Price in USD 55.74
+1.34 (2.46%)
At close: Dec 10, 2025
BILL Holdings Revenue
BILL Holdings had revenue of $395.74M USD in the quarter ending September 30, 2025, with 10.40% growth. This brings the company's revenue in the last twelve months to $1.50B, up 11.63% year-over-year. In the fiscal year ending June 30, 2025, BILL Holdings had annual revenue of $1.46B with 13.36% growth.
Revenue (ttm)
$1.50B
Revenue Growth
+11.63%
P/S Ratio
3.74
Revenue / Employee
$634.46K
Employees
2,364
Market Cap
4.18B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.46B | 172.40M | 13.36% |
| Jun 30, 2024 | 1.29B | 231.70M | 21.89% |
| Jun 30, 2023 | 1.06B | 416.51M | 64.88% |
| Jun 30, 2022 | 641.96M | 403.69M | 169.43% |
| Jun 30, 2021 | 238.27M | - | - |
| Jun 30, 2020 | - | - | - |
| Jun 30, 2019 | 108.35M | 43.49M | 67.04% |
| Jun 30, 2018 | 64.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |